Nisa Investment Advisors’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20
Closed -$238 3049
2025
Q1
$238 Sell
20
-45
-69% -$700 ﹤0.01% 2907
2024
Q4
$1K Hold
65
﹤0.01% 2681
2024
Q3
$729 Hold
65
﹤0.01% 2649
2024
Q2
$350 Sell
65
-25
-28% -$145 ﹤0.01% 2748
2024
Q1
$612 Buy
90
+15
+20% +$105 ﹤0.01% 2468
2023
Q4
$509 Sell
75
-1,530
-95% -$8.66K ﹤0.01% 2402
2023
Q3
$8.04K Buy
+1,605
New +$9.55K ﹤0.01% 2218
2023
Q1
Sell
-2,100
Closed -$18K 2558
2022
Q4
$18K Hold
2,100
﹤0.01% 2081
2022
Q3
$21K Hold
2,100
﹤0.01% 2036
2022
Q2
$27K Buy
+2,100
New +$21.5K ﹤0.01% 1950

Other funds holding CLPT

Nisa Investment Advisors's CLPT Position: Q2 2025 in Review

Nisa Investment Advisors sold out of ClearPoint Neuro (CLPT) in Q2 2025, closing a stake of 20 shares — an estimated $238 sold.

Nisa Investment Advisors first reported a position in CLPT in Q2 2022 and held it in 10 quarters. The position peaked at $27K in Q2 2022. 96 funds tracked by Wall St. Rank hold CLPT as of Q2 2025.

  • Nisa Investment Advisors reported no remaining ClearPoint Neuro position as of Q2 2025 after selling out during the quarter.
  • Nisa Investment Advisors sold 20 ClearPoint Neuro shares in Q2 2025, an estimated $238.
  • Nisa Investment Advisors first reported a position in ClearPoint Neuro in Q2 2022 and held it in 10 quarters.
  • Nisa Investment Advisors's ClearPoint Neuro position peaked at $27K in Q2 2022.
  • 96 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2025.

Based on Nisa Investment Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.